Literature DB >> 27987616

Deep venous thrombosis associated with caval extension of iliac stents.

Erin H Murphy1, Blake Johns2, Elliot Varney2, William Buck2, Arjun Jayaraj2, Seshadri Raju2.   

Abstract

BACKGROUND: It is generally difficult to place an iliac vein stent precisely at the iliocaval junction with venographic control or even with intravascular ultrasound guidance. Furthermore, mechanical properties of the Wallstent (Boston Scientific, Marlborough, Mass) can predispose precisely placed stents to distal displacement or stent collapse. Our center has thus advocated extending Wallstents 3 to 5 cm into the inferior vena cava to prevent complications of missed proximal lesions or stent migration. This technique has gradually been accepted, and concerns of jailing of contralateral flow were not initially recognized. We analyzed deep venous thrombosis (DVT) incidence following iliocaval stenting with two alternative techniques: (1) Wallstents with 3- to 5-cm extension into the inferior vena cava; and (2) a modified Z-stent (Cook Medical, Bloomington, Ind) technique, in which overlapping Wallstents end at the iliac confluence and caval extension is performed with a Z-stent placed at the top of the stack. The function of the Z-stent is to provide improved radial force at the iliocaval confluence and to prevent jailing of contralateral flow with larger stent interstices.
METHODS: There were 755 limbs with consecutive Wallstent caval extensions (2006-2010) and 982 limbs with Z-stent extensions (2011-2015) analyzed for DVT incidence postoperatively.
RESULTS: Demographics were similar for both groups. Mean age was 56 and 58 years in the Wallstent and Z-stent groups, respectively. There was a female predominance (Wallstent, 69%; Z-stent, 67%) and a higher incidence of left-sided disease (Wallstent, 66%; Z-stent, 56%) in both groups. There was a slightly higher incidence of post-thrombotic disease in the Z-stent subgroup (Wallstent, 53%; Z-stent, 68%). Cumulative freedom from contralateral DVT was 99% and 90% in the Z-stent and Wallstent groups, respectively (P < .001) during the 5 years following stent placement. However, all three patients with DVT contralateral to a Z-stent actually had high placement of the Wallstent across the confluence. Thus, no patients with proper Z-stent technique had a contralateral DVT. Cumulative freedom from ipsilateral DVT was 97% and 82% in the Z-stent and Wallstent groups, respectively (P < .001) during the 5 years following stent placement. The decrease in incidence of ipsilateral DVT appeared to be attributable to decreased missed distal lesions with increased operator experience and not attributable to the Z-stent itself.
CONCLUSIONS: Contralateral DVT incidence was significantly lower with the Z-stent modification. In addition, the Z-stent modification provides greater radial strength at the iliac-caval confluence and simplifies simultaneous or sequential bilateral stenting. Use of proper technique and intravascular ultrasound is essential to limit the incidence of ipsilateral DVT.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 27987616     DOI: 10.1016/j.jvsv.2016.09.002

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  10 in total

Review 1.  Endovascular Therapy for Lower Extremity Chronic Deep Venous Occlusive Disease: State of Practice.

Authors:  Vibhor Wadhwa; Ravi N Srinivasa; Kyle J Cooper; Anthony N Hage; Jacob J Bundy; Brooke Spencer; Venu Vadlamudi; Jeffrey Forris Beecham Chick
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

2.  RE: "Long-term follow-up of stenting across the ilio-caval confluence in patients with iliac venous lesions": the value of using IVUS and a dedicated oblique venous stent for deep vein work involving the ilio-caval bifurcation.

Authors:  T Y Tang; R Goh; K Damodharan; E C Choke; T T Chong; Y K Tan
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

3.  Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients.

Authors:  Joseph L McDevitt; Daryl T Goldman; Jacob J Bundy; Anthony N Hage; Neil K Jairath; Joseph J Gemmete; Ravi N Srinivasa; Jeffrey Forris Beecham Chick
Journal:  Diagn Interv Radiol       Date:  2021-01       Impact factor: 2.630

4.  Long-term follow-up of the stenting across the iliocaval confluence in patients with iliac venous lesions.

Authors:  Xicheng Zhang; Yuanhu Jing; Hongfei Sang; Zhaolei Chen; Yuan Sun; Xiaoqiang Li
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

5.  Female Gender is a Predictor of Lower Iliac Vein Stenting Patency Rates.

Authors:  Mohamed S Zaghloul; Othman M Abdul-Malak; Patrick Cherfan; Catherine Go; Zein Saadeddin; Georges E Al-Khoury; Rabih A Chaer; Efthymios D Avgerinos
Journal:  Ann Vasc Surg       Date:  2021-08-28       Impact factor: 1.466

6.  A Case of Inferior Vena Cava Thrombosis Induced by Left Iliac Vein Stents.

Authors:  Wei Wei; Xuemei Jiang; Bo Xu; Yikuan Chen
Journal:  Thorac Cardiovasc Surg Rep       Date:  2018-10-18

7.  A unique complication of double barrel Wallstent technique in iliac-caval stenting.

Authors:  Seshadri Raju; Thomas Powell; Riley Kuykendall; Arjun Jayaraj
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-02-09

8.  A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.

Authors:  Ghulam M Majeed; Krishan Lodhia; Jemima Carter; Jack Kingdon; Rachael I Morris; Adam Gwozdz; Athanasios Saratzis; Prakash Saha
Journal:  J Endovasc Ther       Date:  2021-11-10       Impact factor: 3.089

Review 9.  [Antithrombotic therapy after iliac vein stenting].

Authors:  Wen Zhong; Yan Lou; Chenyang Qiu; Donglin Li; Hongkun Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 10.  Best practices in diagnosis and treatment of chronic iliac vein obstruction.

Authors:  Fabio Henrique Rossi; Thiago Osawa Rodrigues; Nilo Mitsuru Izukawa; Antônio Massamitsu Kambara
Journal:  J Vasc Bras       Date:  2020-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.